Abstract:Telomere Biology Disorders (TBDs) are a group of rare diseases characterized by the presence of short and/or dysfunctional telomeres. They comprise a group of bone marrow failure syndromes, idiopathic pulmonary fibrosis, and liver disease, among other diseases. Genetic alterations (variants) in the genes responsible for telomere homeostasis have been linked to TBDs. Despite the number of variants already identified as pathogenic, an even more significant number must be better understood. The study of TBDs is challenging since identifying these variants is difficult due to their rareness, it is hard to predict their impact on the disease onset, and there are not enough samples to study. Most of our knowledge about pathogenic variants comes from assessing telomerase activity from patients and their relatives affected by a TBD. However, we still lack a cell-based model to identify new variants and to study the long-term impact of such variants on the genes involved in TBDs. Herein, we present a cell-based model using CRISPR base editing to mutagenize the endogenous alleles of 21 genes involved in telomere biology. We identified key residues in the genes encoding 17 different proteins impacting cell growth. We provide functional evidence for variants of uncertain significance in patients with TBDs. We also identified variants resistant to telomerase inhibition that, similar to cells expressing wild-type telomerase, exhibited increased tumorigenic potential using an in vitro tumour growth assay. We believe that such cell-based approaches will significantly advance our understanding of the biology of TBDs and may contribute to the development of new therapies for this group of diseases.

Systematic Analysis of Human Telomeric Dysfunction Using Inducible Telosome/shelterin CRISPR/Cas9 Knockout Cells.

An Activity Switch in Human Telomerase Based on RNA Conformation and Shaped by TCAB1

Analysis of Average Telomere Length in Human Telomeric Protein Knockout Cells Generated by CRISPR/Cas9.

An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase

Krcrispr: an Easy and Efficient Strategy for Generating Conditional Knockout of Essential Genes in Cells

A CRISPR base editing approach for the functional assessment of telomere biology disorder-related genes in human health and aging

High-resolution genome-wide mapping of chromosome-arm-scale truncations induced by CRISPR–Cas9 editing

CRISPR/Cas9-Mediated TERT Disruption in Cancer Cells

User-Friendly Genetic Conditional Knockout Strategies by CRISPR/Cas9

Engineering Human Stem Cell Lines with Inducible Gene Knockout Using CRISPR/Cas9

Efficient CRISPR/Cas9-Mediated Versatile, Predictable, and Donor-Free Gene Knockout in Human Pluripotent Stem Cells.

Precise Gene Deletion and Replacement Using the CRISPR/Cas9 System in Human Cells

Telomeric DNA breaks in human induced pluripotent stem cells trigger ATR-mediated arrest and telomerase-independent telomere damage repair

Precise Gene Modification Mediated by TALEN and Single-Stranded Oligodeoxynucleotides in Human Cells.

GENE-10. A SIMPLE AND EFFICIENT METHOD FOR GENERATING MULTI-ALLELIC INSERTION-DELETION MUTATIONS AND PRECISE DELETIONS IN PRIMARY HUMAN CELL CULTURES

Gene Knockout in Highly Purified Mouse Hematopoietic Stem Cells by CRISPR/Cas9 Technology.

Epigenetic profiles guide improved CRISPR/Cas9-mediated gene knockout in human T cells

Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells

Precise gene deletion and replacement using the CRISPR/Cas9 system in human cells.

Generating Single Cell–Derived Knockout Clones in Mammalian Cells with CRISPR/Cas9

Generation and validation of versatile inducible CRISPRi embryonic stem cell and mouse model